In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic fibrosis.
The diuretic amiloride has been under recent investigation as adjunctive therapy for pulmonary disease in children with cystic fibrosis (CF). In preliminary studies, the antimicrobial activity of this agent alone or combined with beta-lactam agents against reference strains of Pseudomonas aeruginosa...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1988
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172183/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3364958/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.3.395 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|